小方制药
(603207)
| 流通市值：18.35亿 | | | 总市值：54.16亿 |
| 流通股本：5440.00万 | | | 总股本：1.61亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 269,789,667.43 | 129,071,756.14 | 474,583,693.35 | 367,213,945.74 |
| 营业收入 | 269,789,667.43 | 129,071,756.14 | 474,583,693.35 | 367,213,945.74 |
| 二、营业总成本 | 126,585,485.36 | 59,389,758.13 | 236,453,654.47 | 179,224,454.99 |
| 营业成本 | 85,477,394.19 | 44,615,614.34 | 163,189,608.48 | 125,382,134.24 |
| 税金及附加 | 2,444,164.14 | 1,106,789.13 | 3,572,751.12 | 2,664,580.51 |
| 销售费用 | 27,418,140.81 | 8,913,240.57 | 41,581,084.29 | 30,176,932.37 |
| 管理费用 | 8,731,975.43 | 4,260,545.72 | 18,991,942.52 | 12,391,414.28 |
| 研发费用 | 4,824,571.08 | 2,270,871.64 | 15,105,418.01 | 10,672,621.35 |
| 财务费用 | -2,310,760.29 | -1,777,303.27 | -5,987,149.95 | -2,063,227.76 |
| 其中:利息费用 | 61,200.3 | - | 27,781.51 | 22,680.07 |
| 其中:利息收入 | -2,371,960.59 | -1,792,224.97 | -6,050,550.03 | -2,116,494.05 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | 15,584.9 | 15,584.9 |
| 资产减值损失(新) | 2,202.53 | 122,667.07 | -90,259.85 | 49,200.85 |
| 信用减值损失(新) | -1,771,241.59 | -218,838.82 | -217,048.16 | -638,040.49 |
| 其他收益 | 522,836.39 | 356,137.49 | 1,978,671.81 | 1,665,052.33 |
| 四、营业利润 | 141,957,979.4 | 69,941,963.75 | 239,816,987.58 | 189,081,288.34 |
| 加:营业外收入 | 6,000 | - | - | - |
| 减:营业外支出 | 580,000 | 100,000 | 310,077.11 | 310,077.11 |
| 五、利润总额 | 141,383,979.4 | 69,841,963.75 | 239,506,910.47 | 188,771,211.23 |
| 减:所得税费用 | 20,562,728.08 | 9,999,301.58 | 34,235,814.97 | 27,101,723.92 |
| 六、净利润 | 120,821,251.32 | 59,842,662.17 | 205,271,095.5 | 161,669,487.31 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 120,821,251.32 | 59,842,662.17 | 205,271,095.5 | 161,669,487.31 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 120,821,251.32 | 59,842,662.17 | 205,271,095.5 | 161,669,487.31 |
| 扣除非经常损益后的净利润 | 121,237,616.55 | 59,858,859.27 | 205,253,741.46 | 161,660,985.41 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.75 | 0.37 | 1.53 | 1.28 |
| (二)稀释每股收益 | 0.75 | 0.37 | 1.53 | 1.28 |
| 九、综合收益总额 | 120,821,251.32 | 59,842,662.17 | 205,271,095.5 | 161,669,487.31 |
| 归属于母公司股东的综合收益总额 | 120,821,251.32 | 59,842,662.17 | 205,271,095.5 | 161,669,487.31 |
| 公告日期 | 2025-08-26 | 2025-04-30 | 2025-04-30 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |